Navigation Links
Genstar Capital Launches New Senior Care Services Platform UniVita Health and Agrees to Acquire Outsourced Insurance Services Provider, Long Term Care Group
Date:12/1/2008

Newly Formed Platform To Be Developed In Partnership With Industry Veterans Ben and Hugh Lytle

SAN FRANCISCO, Dec. 1 /PRNewswire/ -- Genstar Capital, LLC, a middle market private equity firm that focuses on investments in selected segments of the industrial technology, life sciences, healthcare services, business services and software services industries, today announced that it has signed a definitive agreement to acquire Long Term Care Group, Inc. (LTCG) from Advent International and CCP Equity Partners, in partnership with LTCG's management and industry veterans L. Ben Lytle and Hugh Lytle. LTCG is the initial investment in Genstar's development of a new senior care services platform

Long Term Care Group, based in Eden Prairie, MN was founded in 1996 and is the nation's leader in outsourced services to the long term care insurance industry and an emerging player in the geriatric care services market. LTCG offers a complete range of outsourced services including application processing, underwriting, policy administration, clinical assessments, claims processing, care management, and a robust suite of professional services to long term care insurance companies and their policy holders.

The acquisition of LTCG is the initial investment in Genstar's formation of UniVita Health, a new healthcare services platform centered on the concept of independent aging. UniVita was developed in partnership with healthcare industry veterans Ben and Hugh Lytle who will lead the management team and growth of the new platform.

LTCG is the only company in its market that supports a true "end to end" solution. With 1.3 million policies on its proprietary operating system and 27,000 claims under management, LTCG is the clear market leader. The company has developed deep relationships with many of the industry's leading insurance carriers and provides services to 9 of the top 10 long term care industr
'/>"/>

SOURCE Genstar Capital, LLC
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Genstar Capital Promotes J. Ryan Clark to Principal
2. Genstar Capital Appoints Mark Hanson to Managing Director
3. China West II Files Suit Against Genesis Pharmaceuticals and Capital Research Group Inc, Announces Conference Call Details
4. Foundation Venture Capital Group Invests in Company Working to Protect Healthy Tissue During Cancer Treatment
5. Precision Therapeutics Secures $43 Million in Venture Capital Funding
6. Medipacs Chosen to Present at Invest Southwest Capital Conference
7. Capital BlueCross Receives Prestigious Corporation of the Year Award
8. BELLUS Health Announces Stock Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market
9. Amylin Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
10. SuperGen to Present at the Lazard Capital Markets Fifth Annual Healthcare Conference on November 18, 2008
11. VNUS Medical Technologies to Present at Lazard Capital Markets 5th Annual Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ON, Va., Dec. 2 From more than 1,1...us meaning, joy and peace, the LIFE Foundation has...nducted using the popular photo-sharing Web site f...ideo montage on the LIFE Foundation,s Web site at ...tants submitted one photo and a caption to Flickr....
(Date:12/2/2009)...N, N.J., Dec. 2 Watson P...d that the Federal Trade Commission (FTC) has acce...elating to Watson,s pending acquisition of private...ion of the Hart Scott Rodino waiting period, there.... The parties have now obtained all regulatory ap...
(Date:12/2/2009)...sory for Thursday, Dec. 3 ,, Head of Army,s W...ting of Army Wounded Warriors; Army Embraces Reali..., WASHINGTON, Dec. 2 T...ganization on Disability: ,, WHAT: Wounded ve... Warrior (AW2) program,s National Organization on ...
(Date:12/2/2009)...N and REDMOND, Wash., Dec. 2 /PRNewswire/ -- G...panies will collaborate to give caregivers single-... necessary for providing ongoing care after patien...ir families better tools for managing patients, he...care organization to adopt Microsoft Amalga Unifie...
(Date:12/2/2009)...N, N.J., Dec. 2 Watson P...d that it has completed the acquisition of Arrow G...hase creates a financially strong, global specialt...nnual revenues and operations in more than 20 coun...its to Watson shareholders as a result of this fin...
Breaking Medicine News(10 mins):Health News:Wonders of Life Photo Contest Winners Announced 2Health News:Wonders of Life Photo Contest Winners Announced 3Health News:Watson Receives FTC Clearance for Arrow Acquisition 2Health News:Wounded Vets, CAREER Counselors Gather in Washington as Obama Announces Afghanistan Troop Buildup 2Health News:Golden Living Kick-Starts Post-Acute Health IT with Microsoft HealthVault and Amalga UIS Connection 2Health News:Golden Living Kick-Starts Post-Acute Health IT with Microsoft HealthVault and Amalga UIS Connection 3Health News:Golden Living Kick-Starts Post-Acute Health IT with Microsoft HealthVault and Amalga UIS Connection 4Health News:Watson Completes Acquisition of Arrow Group 2Health News:Watson Completes Acquisition of Arrow Group 3Health News:Watson Completes Acquisition of Arrow Group 4Health News:Watson Completes Acquisition of Arrow Group 5
...iam Aronson, a professor in the department of urol...// in mice it was found that a proper balance in t... the prostate cancer growth rates. The study r...uch as corn, safflower oils and red meats. On the ...
... only one of many potential pieces in the puzzle ...Published in the August 2006 edition of the Americ...cephalogram (EEG) measurements to demonstrate an a... The findings suggest that factors such as p...
...ir price by breaking bones and spraining ankles. /...ir high-heeled sandals, causing several injuries. ... emergency unit at University Hospital of Wales, C...o avoid a hospital trip. Alcohol consumption aggra...
...conception or in early pregnancy can compromise th...y in mice.// The author of the study Sudhansu D... cell and developmental biology and pharmacology a... the active ingredient in marijuana, can disrupt t...
... technology solutions provider with a turnover of ... Chennai-based //Trivitron group to set up a medic...lore. "The potential joint venture will earma...day. "India is the most important market fo...
...orld! Rightly so, for a mother is truly the one th...abling the child with the best right from the word...this age of information, the goodness of breast mi...he inherent wholesomeness of breast milk for infan...
Other Medicine News:Health News:Depression - a Puzzle of Many Pieces 2Health News:Marijuana Use Can Compromise Pregnancy 2Health News:China's Neusoft and Trivitron Plan to Set up Medical Equipments Unit 2Health News:Breast Milk: The Mother of All Milk for Infants 2Health News:Breast Milk: The Mother of All Milk for Infants 3
(Date:12/2/2009)...E, Md., Dec. 2 Novavax, ...tial results from the first stage of a two-stage p...munogenicity of the company,s 2009 H1N1 virus-like...ax is conducting this study in collaboration with ...ion of the vaccine in Mexico and potentially other...
(Date:12/2/2009)...ORK, Dec. 2 Keryx Biopha...d that the U.S. Food and Drug Administration (FDA)...perifosine), the Company,s novel, potentially firs...he phosphoinositide 3-kinase (PI3K)/Akt pathway, f...yeloma. ,, The Fast Track program of the FDA ...
(Date:12/2/2009)...AM, Ala., Dec. 2 Adults are more...h cancer. For adults 65 and over, the odds of losi...man developing prostate cancer are one in six and ...n nine. Vision loss threatens the overall health ..., depression and inability to complete daily tasks...
Breaking Medicine Technology:NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 2NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 3NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 4Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 2Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 3Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 4Risk of Vision Loss in Aging Adults is Greater Than Risk of Breast or Prostate Cancer 2Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease 3B Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver 4745 1Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease 3B Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver 4745 2Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 1Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 2Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 3Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 4Good News for Seniors 3A California Lowest in Overall Medicare Cost Increases Says MedicareSupplementPlans com 52072 1Good News for Seniors 3A California Lowest in Overall Medicare Cost Increases Says MedicareSupplementPlans com 52072 2
... LUND, Sweden--(BUSINESS WIRE)--May 1, 2007 - Teva... AB today,announced that data from a 36-week, rand... study demonstrated that an oral 0.6 mg,dose of la...c,resonance imaging (MRI) disease activity by 38 p... addition, there was a favorable,trend towards red...
...d EDSS progression reduced by 40 percent compared,...wire/ -- Bayer HealthCare,Pharmaceuticals announce...tion(1) of Betaseron(R) (interferon beta-1b) treat...multiple sclerosis (MS),can significantly reduce t...asured by the Expanded Disability Status Scale,(ED...
Other Medicine Technology:Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 2Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 3Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 4Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 5Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 6First of Its Kind Data Show: Immediate Treatment of Early MS,Patients with Betaseron Significantly Delayed Permanent Disability 2First of Its Kind Data Show: Immediate Treatment of Early MS,Patients with Betaseron Significantly Delayed Permanent Disability 3First of Its Kind Data Show: Immediate Treatment of Early MS,Patients with Betaseron Significantly Delayed Permanent Disability 4
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
Medicine Products: